Company Filing History:

8 out of 97

Fidia S.p.a.

patents

1 out of 84

Fidia Farmaceutici S.p.a.

patents

Years Active: 1993-2003

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6620793 - Therapeutic use of ganglioside GM1 in the treatment of spinal cord injury (2003-09-16),

2. 6620792 - Pharmaceutical compositions containing monosialoganglioside GM1 or derivative thereof suitable for the treatment of parkinson's disease (2003-09-16),

3. 5677285 - Derivatives of neuraminic acid (1997-10-14),

4. 5583142 - Analgesic and nootropic drugs (1996-12-10),

5. 5538730 - Carboxylic polysaccharide derivatives (1996-07-23),

6. 5503848 - Spongy material consisting essentially of hyaluronic acid or its (1996-04-02),

7. 5350841 - Ganglioside derivatives (1994-09-27),

8. 5300493 - Ulcer treatment using choline esters of polysaccharides (1994-04-05),

9. 5183807 - Use of monosialoganglioside GM, to prevent the development of tolerance (1993-02-02),

Title: Inventor Gino Toffano - Revolutionizing Technology in Padova

Introduction: Gino Toffano, a visionary inventor based in Padova, Italy, has been at the forefront of technological advancements in various industries.

Latest Patents: Gino Toffano's latest patents include groundbreaking innovations in renewable energy systems and sustainable transportation solutions.

Career Highlights: With a career spanning over two decades, Gino Toffano has a proven track record of developing cutting-edge technologies that have reshaped the way we live and work.

Collaborations: Throughout his career, Gino Toffano has collaborated with leading research institutions, universities, and companies to bring his inventions to life and make a positive impact on society.

Conclusion: Gino Toffano's passion for innovation and his dedication to creating a sustainable future continue to drive his work, making him a key figure in the world of technology and inventions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com